Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Clinical trial NCT05037500 · TERMINATED

Trial details

NCT number: NCT05037500
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2022-01-26
Primary completion: 2024-12-17
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.